Medtronic plc — Director's Dealing 2020

Jan 6, 2020

SEC Form 3/A — Form 3/A

Issuer: Medtronic plc (MDT)
CIK: 0001613103
Period of Report: 2019-11-01

Reporting Person: Wall Brett A. (EVP & Group Pres Restora Thera)

Holdings (Non-Derivative)

Security	Shares	Ownership
Ordinary Shares	13175	Direct

Holdings (Derivative)

Security	Exercise Price	Expiration	Underlying	Shares	Ownership
Stock Option (Right to Buy)	$106.22	2029-10-28	Ordinary Shares (22579)		Direct
Stock Option (Right to Buy)	$78.00	2025-08-03	Ordinary Shares (11154)		Direct
Stock Option (Right to Buy)	$78.00	2025-08-03	Ordinary Shares (1283)		Direct
Stock Option (Right to Buy)	$88.06	2026-08-01	Ordinary Shares (11356)		Direct
Stock Option (Right to Buy)	$88.06	2026-08-01	Ordinary Shares (1136)		Direct
Stock Option (Right to Buy)	$83.97	2027-07-31	Ordinary Shares (11910)		Direct
Stock Option (Right to Buy)	$83.97	2027-07-31	Ordinary Shares (1191)		Direct
Stock Option (Right to Buy)	$89.08	2028-07-30	Ordinary Shares (16946)		Direct
Stock Option (Right to Buy)	$89.08	2028-07-30	Ordinary Shares (1695)		Direct
Stock Option (Right to Buy)	$103.26	2029-07-29	Ordinary Shares (24223)		Direct
Stock Option (Right to Buy)	$103.26	2029-07-29	Ordinary Shares (1615)		Direct
Stock Option (Right to Buy)	$47.00	2023-12-01	Ordinary Shares (12300)		Direct
Stock Option (Right to Buy)	$74.84	2025-01-27	Ordinary Shares (8018)		Direct

Footnotes

F1: The number of shares beneficially owned includes 100 ordinary shares that were inadvertently omitted from Mr. Wall's previous filing.

F2: These options become exercisable at the rate of 25% of the shares granted per year beginning on the first anniversary of grant.

F3: This option became exercisable on June 29, 2018, subject to Medtronic plc's achievement of a pre-specified cash Earnings Per Share Growth Rate for fiscal years 2016 through 2018.